| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |